• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服环孢素油溶液或胶囊后环孢素及其主要代谢产物的单剂量药代动力学。

Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule.

作者信息

Bleck J S, Nashan B, Christians U, Schottmann R, Wonigeit K, Sewing K F

机构信息

Abteilung Allgemeine Pharmakologie, Medizinische Hochschule Hannover, Fed. Rep. of Germany.

出版信息

Arzneimittelforschung. 1990 Jan;40(1):62-4.

PMID:2340002
Abstract

The commercially available oily solution of ciclosporin which has to be suspended before intake is disliked by some patients for bad taste and has a variable bioavailability. In this investigation the oral pharmacokinetics of ciclosporin and its main metabolites 1 and 17 of the oily solution (Sandimmun) and a soft gelatine capsule preparation of ciclosporin were compared in a crossover fashion in 10 kidney allograft recipients. The results demonstrate a bioequivalence of both formulations. In either case metabolite 17 had a significantly longer half-life than either ciclosporin or metabolite 1. At earlier time-points the concentration of ciclosporin could be best correlated with metabolite 1 and at later time-points with metabolite 17. Both metabolites were less correlated with each other in the late absorption phase of ciclosporin.

摘要

市售的环孢素油溶液在服用前必须混悬,一些患者因味道不佳而不喜欢它,并且其生物利用度可变。在本研究中,以交叉方式比较了10例肾移植受者中环孢素油溶液(山地明)及其主要代谢物1和17以及环孢素软胶囊制剂的口服药代动力学。结果表明两种制剂具有生物等效性。在任何一种情况下,代谢物17的半衰期均明显长于环孢素或代谢物1。在较早的时间点,环孢素的浓度与代谢物1的相关性最好,而在较晚的时间点与代谢物17的相关性最好。在环孢素的吸收后期,两种代谢物之间的相关性较低。

相似文献

1
Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule.口服环孢素油溶液或胶囊后环孢素及其主要代谢产物的单剂量药代动力学。
Arzneimittelforschung. 1990 Jan;40(1):62-4.
2
Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.三种不同剂型硝苯地平制剂的药代动力学和生物利用度
Arzneimittelforschung. 1986 Feb;36(2):256-60.
3
[Oral cyclosporine pharmacokinetics in renal transplantation patients].肾移植患者口服环孢素的药代动力学
Yao Xue Xue Bao. 1990;25(1):1-5.
4
[The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites].[水合氯醛及其代谢产物的相对生物利用度和药代动力学]
Arzneimittelforschung. 1998 Jan;48(1):5-12.
5
Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.左乙拉西坦:10%口服溶液(750毫克)与750毫克片剂的相对生物利用度和生物等效性
J Clin Pharmacol. 2003 Dec;43(12):1370-6. doi: 10.1177/0091270003258173.
6
Steady-state concentrations of cyclosporine for therapeutic monitoring.用于治疗监测的环孢素稳态浓度。
Transplant Proc. 1990 Jun;22(3):1339-42.
7
Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients.移植受者服用山地明软胶囊和新山地明后血中环孢素A及代谢物的动力学特征。
Transplant Proc. 1994 Oct;26(5):2964-8.
8
Study on the peroral absorption of the endekapeptide cyclosporine A.环孢素A环状十一肽口服吸收的研究。
Methods Find Exp Clin Pharmacol. 1989 Apr;11(4):281-7.
9
Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
Ther Drug Monit. 1990 Jul;12(4):353-8.
10
[Plasma level studies in volunteers after intramuscular injection of various doses of etofenamate in an oily solution].[志愿者肌肉注射不同剂量依托芬那酯油溶液后的血浆水平研究]
Arzneimittelforschung. 1990 Mar;40(3):305-11.

引用本文的文献

1
Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.类风湿关节炎患者中环孢素A新口服剂型的相对生物利用度。
Br J Clin Pharmacol. 1995 Feb;39(2):172-5. doi: 10.1111/j.1365-2125.1995.tb04425.x.
2
Enhancement of the oral absorption of cyclosporin in man.人中环孢素口服吸收的增强。
Br J Clin Pharmacol. 1992 Jul;34(1):60-4. doi: 10.1111/j.1365-2125.1992.tb04108.x.